Uniqure Nv Stock Buy Hold or Sell Recommendation
| QURE Stock | USD 6.02 0.03 0.50% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Uniqure NV is 'Strong Sell'. Macroaxis provides Uniqure NV buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding QURE positions.
Check out Uniqure NV Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide. Note, we conduct extensive research on individual companies such as Uniqure and provide practical buy, sell, or hold advice based on investors' constraints. Uniqure NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Uniqure |
Execute Uniqure NV Buy or Sell Advice
The Uniqure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Uniqure NV. Macroaxis does not own or have any residual interests in Uniqure NV or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Uniqure NV's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Uniqure NV Trading Alerts and Improvement Suggestions
| Uniqure NV had very high historical volatility over the last 90 days | |
| Uniqure NV has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 15.84 M. Net Loss for the year was (308.48 M) with loss before overhead, payroll, taxes, and interest of (87.37 M). | |
| Uniqure NV currently holds about 500.52 M in cash with (145.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Uniqure NV has a frail financial position based on the latest SEC disclosures | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU |
Uniqure NV Returns Distribution Density
The distribution of Uniqure NV's historical returns is an attempt to chart the uncertainty of Uniqure NV's future price movements. The chart of the probability distribution of Uniqure NV daily returns describes the distribution of returns around its average expected value. We use Uniqure NV price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Uniqure NV returns is essential to provide solid investment advice for Uniqure NV.
| Mean Return | 0.14 | Value At Risk | -6.29 | Potential Upside | 11.07 | Standard Deviation | 5.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Uniqure NV historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Uniqure Stock Institutional Investors
| Shares | Ameriprise Financial Inc | 2024-06-30 | 851.1 K | Two Sigma Investments Llc | 2024-09-30 | 804.9 K | Privium Fund Management B.v. | 2024-09-30 | 744.9 K | D. E. Shaw & Co Lp | 2024-09-30 | 743.5 K | Macquarie Group Ltd | 2024-06-30 | 706.2 K | Avidity Partners Management Lp | 2024-09-30 | 673.6 K | Jpmorgan Chase & Co | 2024-06-30 | 665.6 K | Hudson Bay Capital Management Lp | 2024-09-30 | 635.5 K | Bnp Paribas Arbitrage, Sa | 2024-06-30 | 598.9 K | Vestal Point Capital Lp | 2024-06-30 | 4.8 M | Nantahala Capital Management, Llc | 2024-09-30 | 2.8 M |
Uniqure NV Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 143.4M | (133.0M) | 311.7M | (328.2M) | 13.4M | 14.2M | |
| Free Cash Flow | (105.3M) | (144.3M) | 270.5M | (162.7M) | (153.1M) | (145.4M) | |
| Depreciation | 6.7M | 10.6M | 7.3M | 8.5M | 11.9M | 6.8M | |
| Other Non Cash Items | 3.4M | (19.4M) | (27.3M) | (16.2M) | 32.5M | 34.1M | |
| Capital Expenditures | 6.6M | 9.5M | 17.4M | 17.7M | 7.2M | 10.8M | |
| Net Income | (124.2M) | (125.0M) | 329.6M | (126.8M) | (308.5M) | (293.1M) | |
| End Period Cash Flow | 380.7M | 247.7M | 559.4M | 231.2M | 244.5M | 212.8M | |
| Change To Inventory | (382K) | 4.8M | 7.0M | (6.9M) | (6.7M) | (6.4M) | |
| Change To Netincome | 18.4M | 36.6M | (5.3M) | 16.6M | 19.1M | 14.7M | |
| Investments | (6.6M) | (9.5M) | (67.4M) | (182.7M) | (433.5M) | (411.8M) |
Uniqure NV Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Uniqure NV or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Uniqure NV's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Uniqure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | 4.28 | |
σ | Overall volatility | 5.88 | |
Ir | Information ratio | 0 |
Uniqure NV Volatility Alert
Uniqure NV exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Uniqure NV's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Uniqure NV's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Uniqure NV Fundamentals Vs Peers
Comparing Uniqure NV's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Uniqure NV's direct or indirect competition across all of the common fundamentals between Uniqure NV and the related equities. This way, we can detect undervalued stocks with similar characteristics as Uniqure NV or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Uniqure NV's fundamental indicators could also be used in its relative valuation, which is a method of valuing Uniqure NV by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Uniqure NV to competition |
| Fundamentals | Uniqure NV | Peer Average |
| Return On Equity | -1.48 | -0.31 |
| Return On Asset | -0.17 | -0.14 |
| Operating Margin | (17.77) % | (5.51) % |
| Current Valuation | (74.21 M) | 16.62 B |
| Shares Outstanding | 48.74 M | 571.82 M |
| Shares Owned By Insiders | 9.23 % | 10.09 % |
| Shares Owned By Institutions | 81.95 % | 39.21 % |
| Number Of Shares Shorted | 3.17 M | 4.71 M |
| Price To Earning | 2.51 X | 28.72 X |
| Price To Book | 5.26 X | 9.51 X |
| Price To Sales | 10.26 X | 11.42 X |
| Revenue | 15.84 M | 9.43 B |
| Gross Profit | (87.37 M) | 27.38 B |
| EBITDA | (253.1 M) | 3.9 B |
| Net Income | (308.48 M) | 570.98 M |
| Cash And Equivalents | 500.52 M | 2.7 B |
| Cash Per Share | 10.71 X | 5.01 X |
| Total Debt | 138.41 M | 5.32 B |
| Debt To Equity | 0.29 % | 48.70 % |
| Current Ratio | 10.84 X | 2.16 X |
| Book Value Per Share | 1.15 X | 1.93 K |
| Cash Flow From Operations | (145.93 M) | 971.22 M |
| Short Ratio | 4.20 X | 4.00 X |
| Earnings Per Share | (4.95) X | 3.12 X |
| Target Price | 17.58 | |
| Number Of Employees | 480 | 18.84 K |
| Beta | 0.9 | -0.15 |
| Market Capitalization | 293.43 M | 19.03 B |
| Total Asset | 831.69 M | 29.47 B |
| Retained Earnings | (890.41 M) | 9.33 B |
| Working Capital | 578.18 M | 1.48 B |
| Current Asset | 209.49 M | 9.34 B |
| Current Liabilities | 24.38 M | 7.9 B |
Note: Disposition of 3228 shares by Gut Robert of Uniqure NV at 18.88 subject to Rule 16b-3 [view details]
Uniqure NV Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Uniqure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Uniqure NV Buy or Sell Advice
When is the right time to buy or sell Uniqure NV? Buying financial instruments such as Uniqure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Uniqure NV in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Outsourcing Thematic Idea Now
Outsourcing
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Uniqure NV Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Uniqure Stock refer to our How to Trade Uniqure Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Uniqure NV. If investors know Uniqure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Uniqure NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Earnings Share (4.95) | Revenue Per Share 0.591 | Quarterly Revenue Growth 0.625 | Return On Assets (0.17) |
The market value of Uniqure NV is measured differently than its book value, which is the value of Uniqure that is recorded on the company's balance sheet. Investors also form their own opinion of Uniqure NV's value that differs from its market value or its book value, called intrinsic value, which is Uniqure NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Uniqure NV's market value can be influenced by many factors that don't directly affect Uniqure NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Uniqure NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Uniqure NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Uniqure NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.